4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-008860
Chief Scientific Officer sold 383 shares at $12.68 ($4,857)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2022-02-09 | Sale | −383 | $12.68 | $4,857 | 87,301 | D: show line 1 in the form |
| Open-market sales · 383 sh · avg $12.68 · $4,857 | |||||||
Loading xslF345X03/doc4.xml…